Act now, Fiasp patients urged

Diabetes drug was set to vanish from the Australian market in days – but there’s now temporary relief for patients Patients who want to stay on the diabetes medicine Fiasp will need to act quickly, says health minister Mark Butler. Earlier this month, Novo Nordisk, the sponsor of Fiasp, decided to withdraw it from the